Spravato treatment is a prescription option used in certain cases of depression when other approaches may not have provided enough relief. It is administered under medical supervision and follows a structured treatment process. Patients often have questions about how it works and what to expect during care. Here is more information about Spravato treatment:
Who Is Spravato For?
Healthcare providers prescribe Spravato treatment for patients with treatment-resistant depression. Medical professionals define this condition clearly, and it applies to adults who have tried at least two different antidepressants without seeing sufficient improvement. This medication is a fundamental option for individuals who require a different pharmacological approach.
The nasal spray also helps adults who experience major depressive disorder with suicidal thoughts or behaviors. Patients must seek immediate emergency medical help if they are in crisis, and they can explore this medication once they are in a safe state. A medical evaluation determines eligibility, making sure the treatment aligns with the patient’s specific health needs.
How Is It Administered?
The administration of Spravato treatment follows a strict clinical protocol to maintain patient safety. Medical staff guides the patient through the process, and the environment remains controlled throughout the entire appointment. Here’s what patients can expect:
- Medical Intake: Staff check vital signs and confirm the patient feels well enough to proceed.
- Self-Administration: The patient sprays the device into their own nose under the direct observation of a healthcare worker.
- Observation Period: Patients stay in a quiet room while medical professionals monitor them for about two hours.
- Discharge Check: Staff verifies that the patient is stable, so they can release the individual to a designated driver.
The clinical team oversees every step of the appointment to maximize safety.
What Safety Steps Matter?
Safety remains a key focus during every single medical appointment. Spravato treatment can cause side effects like dizziness, anxiety, or dissociation, and patients may feel sleepy after taking the dose. Medical staff watch for these reactions so they can intervene quickly if a patient experiences discomfort.
Patients cannot drive themselves home after an appointment. The medication impairs cognitive and motor functions temporarily, and individuals must arrange for a safe ride from the clinic. Patients should plan to rest at home, and they can resume their normal daily activities the following morning. The nasal spray can also cause temporary increases in blood pressure, which requires clinical oversight. Staff will make sure the patient’s health markers return to acceptable levels before allowing them to leave the facility.
What Does Treatment Involve?
The treatment schedule changes as the patient moves through different phases of care. Doctors establish a specific timeline, and patients must commit to the recommended frequency to achieve the best medical outcomes. Here are the standard phases patients often pass through:
- Initial Phase: Patients visit the clinic twice a week for the first four weeks of care.
- Adjustment Phase: The frequency drops to once a week, which typically occurs during the second month.
- Maintenance Phase: Doctors may reduce visits to once every two weeks, depending entirely on the patient’s progress.
Medical providers evaluate the patient regularly to determine the ongoing treatment schedule.
Learn More About Spravato Treatment
Spravato treatment provides a clinical option for adults facing treatment-resistant depression. The esketamine treatment requires strict in-office monitoring, and patients follow a specific schedule over several months. Individuals must coordinate this care with their healthcare providers, and they must adhere to all safety guidelines regarding transportation and rest. Contact a qualified healthcare provider near you to schedule your appointment and learn more about Spravato today.
